This is a Pfizer organised and funded promotional symposium available to GB HCPs only: 

• Which patients are eligible for COVID-19 treatments
• COVID-19 pathways in primary care
• An overview of the antiviral treatments available
• Practical advice and patient case studies

The Pfizer product Paxlovid (nirmatrelvir/ritonivir) will be discussed at this symposium. PI and AE reporting is available below and will also be available in the symposium. 

PAXLOVID Prescribing Information for Great Britain can be found here

Adverse Events should be reported. Reporting forms and information can be found at https://coronavirus-yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse Events should also be reported to Pfizer Medical Information on 01304 616161

PP-PAX-GBR-1158 
Date of prep: Oct 2023